The challenges, opportunities, and strategic outlook for oncology research centers.
Mats Sundgren, PhD
Advertisement
An advisor in health data strategy for industry and academia.
Articles by Mats Sundgren, PhD
The potential of next-generation platforms in transforming patient recruitment.
A use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
How evidence generated by the latest IgniteData ‘real-setting’ pilot study supports the case for clinical trial transformation.
Advances in technology open door for improved EHR to EDC transfer process.
Growing availability of RWD leads new drug development process.
Advertisement
Latest Updated Articles
Harnessing Unstructured Data and Hospital InteroperabilityNovember 15th 2024
Streamlining Clinical Trials with eSource: Insights from MSKAugust 19th 2024
Advances in eSource Interoperability Between EHR and EDCDecember 30th 2022
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Seeks Public Input on Early-Phase Clinical Trial Design for Ibogaine
2
Mixed Outsourcing Models Are Spreading. Is Sponsor Oversight Keeping Up?
3
FDA Releases Transparency Roadmap Outlining Disclosure Priorities Across Drug Development and Regulatory Review
4
ACT Brief: Ibogaine Trial Design Guidance, Outsourcing Model Oversight Gaps, and Kidney Disease Partnership
5